Premium Nahrungsergänzungsmittel | artgerecht

Löfgren Syndrome – Symptoms, Diagnosis and Treatment

Löfgren syndrome is an acute form of sarcoidosis characterized by fever, joint swelling, erythema nodosum, and enlarged lymph nodes in the chest.

Regular tips about health Regular tips about health

Things worth knowing about "Löfgren Syndrome"

Löfgren syndrome is an acute form of sarcoidosis characterized by fever, joint swelling, erythema nodosum, and enlarged lymph nodes in the chest.

What is Löfgren Syndrome?

Löfgren syndrome is an acute and typically self-limiting form of sarcoidosis, an inflammatory disease in which small clusters of immune cells – known as granulomas – form in various tissues. It was first described in 1953 by Swedish physician Sven Löfgren. The syndrome most commonly affects younger adults and is recognized by a characteristic combination of symptoms that appear together.

Causes

The exact cause of Löfgren syndrome is not yet fully understood. It is considered an immune-mediated condition in which the immune system overreacts and forms granulomas. Several contributing factors have been identified:

Genetic predisposition (specific HLA genotypes, particularly HLA-DRB1*03)
Infectious triggers, such as bacteria like Mycobacterium tuberculosis or Propionibacterium acnes
Environmental factors and occupational exposure to certain dusts or chemicals

Symptoms

Löfgren syndrome is defined by a classic triad of three hallmark findings:

Erythema nodosum: Painful, reddish nodules beneath the skin, typically appearing on the lower legs
Bilateral hilar lymphadenopathy: Enlargement of lymph nodes on both sides of the lung roots, visible on chest X-ray
Acute arthritis: Joint pain and swelling, most commonly affecting the ankles, knees, and wrists

Additional common symptoms include:

Fever
General malaise and fatigue
Night sweats
Cough or mild respiratory discomfort

Diagnosis

The diagnosis of Löfgren syndrome is primarily clinical, meaning it is based on the characteristic pattern of symptoms. Invasive procedures such as tissue biopsy are generally not required when the classic symptom combination is present. The following diagnostic tools are commonly used:

Chest X-ray: To confirm bilateral hilar lymphadenopathy
Blood tests: Elevated inflammatory markers (CRP, ESR), elevated angiotensin-converting enzyme (ACE), possible hypercalcemia
CT scan of the chest: For a more detailed assessment of lymph nodes and lung tissue in unclear cases
Skin biopsy: For histological confirmation of erythema nodosum if needed
Exclusion of other conditions: Such as tuberculosis, lymphoma, or other causes of lymph node enlargement

Treatment

In most patients, Löfgren syndrome follows a self-limiting course, resolving spontaneously within 6 to 24 months without specific treatment. The overall prognosis is excellent. Treatment focuses on relieving symptoms:

Symptomatic Treatment

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen: To relieve joint inflammation and fever
Rest and leg elevation: Recommended when erythema nodosum is pronounced
Compression stockings: To reduce leg swelling

Corticosteroids

In severe cases or when NSAIDs are insufficient, corticosteroids such as prednisolone may be prescribed. These medications have a strong anti-inflammatory effect and can accelerate symptom resolution.

Follow-up Care

Regular medical check-ups are important to ensure complete resolution of the disease and to detect any transition to chronic sarcoidosis. A small proportion of patients may go on to develop a chronic form of the condition.

Prognosis

Löfgren syndrome carries a very favorable prognosis compared to other forms of sarcoidosis. Spontaneous remission rates exceed 80%. Patients carrying the HLA-DRB1*03 genotype are particularly likely to experience a benign course.

References

Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. New England Journal of Medicine. 2007;357(21):2153-2165.
Mana J, Gomez-Vaquero C, Montero A, et al. Löfgren's syndrome revisited: a study of 186 patients. American Journal of Medicine. 1999;107(3):240-245.
Spagnolo P, Rossi G, Trisolini R, et al. Pulmonary sarcoidosis. Lancet Respiratory Medicine. 2018;6(5):389-402.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.